Lynnea Olivarez Email & Phone Number

✔️ Savvy life sci communicator with experience spanning industry, agency and government✔️ Convener across all levels and functions to drive comms supporting the full drug development lifecycle✔️ Passion for translating brilliant science into digestible yet compelling insights with precisionMORE ABOUT MEA versatile life science comms practitioner, I specialize in integrated PR, digital and social media, employee engagement and patient advocacy strategies. I'm a natural convener and founded in 2023 the biopharma communicator community Ticket to Biotech (T2B), after 15+ years in the field. My complementary consultancy, Rimor Advisory, is my response to a profession-wide shift from traditional comms towards strategic advisor. Rimor positions corporate affairs as a pivotal partner in achieving business success. I previously managed corporate communications as a VP at gene therapy company Encoded Tx. Before that, PR News recognized me in their 2020 Annual Top Women in PR Awards for my work at CRISPR leader Intellia Tx. I also guided strategic comms for dozens of clients at PR firms Ten Bridge Communications and MacDougall Advisors. Earlier in my career, I led mar-comm for the MA Life Sciences Center and global IT communications at Novartis Biomedical Research. A summa cum laude Northeastern University graduate, I'm 2024 president of the Public Relations Society of America SF Bay Area Chapter; 2024 Fierce Pharma PR & Comms Rising Stars advisor; and chair of the American Society of Gene and Cell Therapy Communications Committee.CAREER ACCOMPLISHMENTS SNAPSHOT🔹 Executed integrated comms and patient ed strategy for the first potentially curative, systemically delivered in vivo genome editing therapy FIH trial🔹 Developed strategic comms for myriad orgs, campaigns and therapeutics, including approval, launch and pricing of the first FDA-approved gene therapy for a genetic disease🔹 Conceived emerging data publication’s PR approach that resulted in $300M+ biobucks term sheet 🔹 Liaised with eight medtech / pharma cos, top nonprofit academic research org and FDA to publish findings from landmark global cardiovascular study enrolling >25K subjects🔹 Led rebrand of MA state agency charged with administering $1B life science initiative🔹 Spearheaded pandemic comms for hybrid workforce of 200 to ensure normal course of business🔹 Managed a big pharma research division’s global internal informatics / tech comms for 4K+ employees🔹 Selected as social / digital content partner for premier CGT annual meetingWEBSITEShttps://linktr.ee/lynneaolivarez

Listed skills include Press Releases, Corporate Communications, Media Relations, Leadership, and 42 others.

• 

  Northeastern University

  Minor: Political Science